Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Br J Pharmacol ; 158(5): 1356-65, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19785656

ABSTRACT

BACKGROUND AND PURPOSE: Ca(2+)-activated Cl(-) currents (I(Cl(Ca))) in arterial smooth muscle cells are inhibited by phosphorylation. The Ca(2+)-activated Cl(-) channel (Cl(Ca)) blocker niflumic acid (NFA) produces a paradoxical dual effect on I(Cl(Ca)), causing stimulation or inhibition at potentials below or above 0 mV respectively. We tested whether the effects of NFA on I(Cl(Ca)) were modulated by phosphorylation. EXPERIMENTAL APPROACH: I(Cl(Ca)) was elicited with 500 nM free internal Ca(2+) in rabbit pulmonary artery myocytes. The state of global phosphorylation was altered by cell dialysis with either 5 mM ATP or 0 mM ATP with or without an inhibitor of calmodulin-dependent protein kinase type II, KN-93 (10 microM). KEY RESULTS: Dephosphorylation enhanced the ability of 100 microM NFA to inhibit I(Cl(Ca)). This effect was attributed to a large negative shift in the voltage-dependence of block, which was converted to stimulation at potentials <-50 mV, approximately 70 mV more negative than cells dialysed with 5 mM ATP. NFA dose-dependently blocked I(Cl(Ca)) in the range of 0.1-250 microM in cells dialysed with 0 mM ATP and KN-93, which contrasted with the stimulation induced by 0.1 microM, which converted to block at concentrations >1 microM when cells were dialysed with 5 mM ATP. CONCLUSIONS AND IMPLICATIONS: Our data indicate that the presumed state of phosphorylation of the pore-forming or regulatory subunit of Cl(Ca) channels influenced the interaction of NFA in a manner that obstructs interaction of the drug with an inhibitory binding site.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Calcium/physiology , Chloride Channels/metabolism , Myocytes, Smooth Muscle/drug effects , Niflumic Acid/pharmacology , Pulmonary Artery/drug effects , Adenosine Triphosphate/pharmacology , Animals , Benzylamines/pharmacology , Calcium-Calmodulin-Dependent Protein Kinase Type 2/antagonists & inhibitors , In Vitro Techniques , Myocytes, Smooth Muscle/metabolism , Patch-Clamp Techniques , Phosphorylation , Protein Subunits/metabolism , Pulmonary Artery/metabolism , Rabbits , Sulfonamides/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...